Reliance Global (Nasdaq: EZRA) eyes $11M Altruis sale to retire term debt
Rhea-AI Filing Summary
Reliance Global Group, Inc. entered into a non-binding letter of intent on July 30, 2026 to sell substantially all operating assets of its Altruis Benefit Consulting subsidiary, a Michigan-based health insurance agency and benefits consulting business, to a third-party buyer for $11,000,000 in cash, with the buyer also assuming certain specified liabilities.
About $9,350,000 of the purchase price would be paid in cash at closing, subject to a working capital adjustment, and about $1,650,000 would be placed in an interest-bearing escrow account for indemnification, to be released to Reliance 18 months after closing, subject to definitive agreements. A related press release states that, if completed as contemplated, the all-cash, non-dilutive transaction is expected to retire 100% of the company’s term debt and generate approximately $7.6 million of aggregate incremental cash, supporting continued investment in its AI platform and RELI Exchange InsurTech operations.
The parties are targeting a closing on or before September 24, 2026, subject to negotiation and execution of definitive agreements and multiple conditions, including due diligence, carrier appointment continuity, lien releases, third-party consents, board approvals and buyer financing. Reliance agreed to an exclusivity period through October 16, 2026, but the LOI remains non-binding on principal terms, and there is no assurance the transaction will be completed.
Positive
- $11,000,000 all-cash LOI for Altruis is expected, if completed, to retire 100% of Reliance’s term debt and generate about $7.6 million of aggregate incremental cash.
- Management highlights that the contemplated sale is non-dilutive, with no new shares issued, while funding continued investment in the Company’s AI platform and RELI Exchange InsurTech operations.
Negative
- The Altruis sale is based only on a non-binding LOI, with no assurance definitive agreements will be executed or that the transaction will close on the described terms or timeline.
- Forward-looking statements note risks that net cash proceeds could be lower than anticipated after expenses, taxes, escrows and debt repayment, and that Reliance would lose the revenue and operating cash flow historically contributed by Altruis.
Insights
Analyzing...
8-K Event Classification
Key Figures
Key Terms
non-binding letter of intent regulatory
working capital adjustment financial
interest-bearing escrow account financial
term debt financial
InsurTech technical
forward-looking statements regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What transaction did Reliance Global Group (EZRA) announce involving Altruis Benefit Consulting?
How will the $11 million Altruis sale proceeds be structured for Reliance Global Group (EZRA)?
What financial impact does Reliance Global Group (EZRA) expect if the Altruis sale closes?
When is Reliance Global Group (EZRA) targeting closing for the proposed Altruis transaction?
What exclusivity obligations did Reliance Global Group (EZRA) agree to in the Altruis LOI?
What are the key risks and conditions around Reliance Global Group’s (EZRA) proposed Altruis sale?
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
(Exact Name of Registrant as Specified in Its Charter)
| (State
or Other Jurisdiction of Incorporation) |
(Commission
File Number) |
(IRS
Employer Identification No.) |
| (Address of Principal Executive Offices) | (Zip Code) |
(Registrant’s Telephone Number, Including Area Code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| The
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01. Regulation FD Disclosure.
On August 3, 2026, Reliance Global Group, Inc. (the “Company”) issued a press release announcing its entry into the non-binding letter of intent described in Item 8.01 of this Current Report on Form 8-K. A copy of the press release is furnished as Exhibit 99.1 hereto.
The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 8.01. Other Events.
On July 30, 2026, the Company entered into a non-binding letter of intent (the “LOI”) pursuant to which the Company would sell substantially all of the operating assets of its Altruis Benefit Consulting (“Altruis”) subsidiary, a Michigan-based health insurance agency and benefits consulting business, to a third party purchaser or its affiliates or owners (the “Buyer”), which would also assume certain specified liabilities of Altruis, for a cash purchase price of $11,000,000 (the “Proposed Transaction”).
Under the terms of the LOI, approximately $9,350,000 of the purchase price would be paid to the Company in cash at closing (subject to a working capital adjustment), with approximately $1,650,000 to be held in an interest-bearing escrow account for indemnification purposes, the remaining balance of which, together with accrued interest, would be released to the Company 18 months following closing, in each case subject to the terms and conditions to be set forth in definitive agreements.
The parties are targeting a closing of the Proposed Transaction on or before September 24, 2026, subject to the negotiation and execution of definitive agreements and the satisfaction of closing conditions, including, among others, continuity of Altruis’s material carrier appointments, lender lien releases and other third-party consents, satisfactory completion of due diligence (including a confirmatory quality-of-earnings review), board approvals and the Buyer’s ability to obtain financing for the transaction.
The LOI is non-binding as to the principal economic and other terms of the Proposed Transaction as described above, except for certain customary provisions relating to exclusivity, confidentiality and allocation of expenses, which are binding on the parties. Among these, the Company has agreed, for a period commencing July 30, 2026 and continuing through October 16, 2026 (subject to extension in certain circumstances), not to solicit, negotiate or accept competing proposals for the acquisition of Altruis’s assets or equity, subject to early termination in certain circumstances.
There can be no assurance that the parties will negotiate or execute definitive agreements, that the Proposed Transaction will be consummated on the terms described above, on the contemplated timeline, or at all, or that any definitive agreements, if executed, will not contain terms materially different from those described in this Item 8.01.
Forward-Looking Statements
This Current Report on Form 8-K, including Exhibit 99.1, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding, among other things, the Proposed Transaction, the anticipated terms, timing and consummation thereof, the Company’s expected use of proceeds, and the anticipated effects of the Proposed Transaction on the Company’s cash position, capital structure and financial flexibility. These statements are subject to risks and uncertainties, including that the LOI is non-binding as to the principal terms of the Proposed Transaction, that definitive agreements may not be negotiated or executed, and that the Proposed Transaction may not be consummated on the terms described, on the contemplated timeline, or at all. Additional risk factors are discussed in the Company’s filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements except as required by law.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. | Description | |
| 99.1 | Press Release of Reliance Global Group, Inc., dated August 3, 2026. | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| Reliance Global Group, Inc. | ||
| Dated: August 5, 2026 | By: | /s/ Ezra Beyman |
| Ezra Beyman | ||
| Chief Executive Officer | ||
Exhibit 99.1
Reliance Global Group Signs LOI to Sell Altruis Benefit Consulting for $11 Million in Cash
Transaction
Expected to Generate Approximately $7.6 Million of Aggregate Incremental Cash
After Retiring 100% of the Company’s Term Debt
All-Cash,
Non-Dilutive Transaction Would Support Continued Investment in the Company’s
Proprietary AI Platform and RELI Exchange InsurTech Operations
LAKEWOOD, N.J., August 3, 2026 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: EZRA) (“Reliance,” “EZRA” or the “Company”), an InsurTech company leveraging artificial intelligence, cloud computing and advanced technologies to transform the insurance agency/brokerage industry, today announced that it has entered into a non-binding letter of intent (the “LOI”) to sell substantially all of the operating assets of its Altruis Benefit Consulting (“Altruis”) subsidiary, a Michigan-based health insurance agency and benefits consulting business, for $11 million in cash. The transaction would transform the Company’s balance sheet, retiring all of its term debt while adding a substantial amount of cash, without issuing a single share of stock. The LOI is non-binding, and there can be no assurance that definitive agreements will be executed or that the proposed transaction will be completed on the terms described, on the contemplated timeline, or at all.
Key Terms and Expected Impact
| ● | $11 million in cash for a single subsidiary. Reliance would retain its proprietary AI platform, RELI Exchange and its other insurance operations. Approximately $9.35 million would be paid at closing, with $1.65 million held in an interest-bearing escrow account, the remaining balance of which, plus accrued interest, would be released to the Company 18 months after closing. |
| ● | Approximately $7.6 million of incremental cash. After fully repaying its Oak Street Funding term loan — the Company’s only term debt of approximately $4.4 million. The transaction is expected to generate approximately $7.6 million of incremental cash in the aggregate: approximately $5 million of net proceeds at closing, before transaction expenses and any taxes; approximately $1.0 million of cash released from restriction as loan collateral; and $1.65 million upon release of the indemnification escrow 18 months after closing. |
| ● | Zero dilution. The entire purchase price is payable in cash — not buyer stock, not a seller note, not an earnout. |
| ● | Interest expense eliminated. Repaying the term loan would eliminate the entire principal and interest expense— approximately $1 million annually — making that cash available for operations and growth. |
| ● | Targeted closing. The parties are targeting a closing within the next 60 days, subject to customary closing conditions. |
Strategic Rationale
The proposed sale would mark a significant step in the portfolio strategy Reliance launched in 2025: monetizing mature insurance distribution assets and redeploying that capital into the Company’s future growth opportunities. Altruis is a profitable, well-run business that has grown under Reliance’s ownership, and the proposed price reflects the value the Company built there. With the proceeds, Reliance would fund the continued build-out of its AI platform, launched in July 2026, and its RELI Exchange InsurTech network, while retaining its other insurance operations and their recurring commission revenue.
“We believe that this proposed transaction speaks for itself: an $11 million all-cash price for one of our subsidiaries underscores the value of the business we have built at Reliance,” said Ezra Beyman, Chairman and Chief Executive Officer of Reliance Global Group. “ If completed, this sale would allow us to convert a portion of that value into cash and put it to work in the areas we believe offer the greatest growth potential — our AI platform and our RELI Exchange network.”
“If completed as contemplated, Reliance would emerge with no term debt, a substantially stronger cash position, and not one new share issued,” Mr. Beyman continued. “Very few companies of our size get the opportunity to reset their balance sheet this decisively without dilution. We intend to move quickly toward definitive agreements and a targeted closing, and we look forward to updating shareholders on our progress.”
About Reliance Global Group, Inc.
Reliance Global Group, Inc. (Nasdaq: EZRA) is an InsurTech company leveraging artificial intelligence, cloud computing and advanced technologies to transform the insurance agency/brokerage industry. Through its growing portfolio of proprietary AI solutions and insurance operations, the Company is focused on enhancing operational efficiency, improving customer experiences and creating long-term shareholder value. Further information about the Company can be found at https://www.relianceglobalgroup.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements other than statements of historical fact and may be identified by the use of words or expressions such as “may,” “should,” “could,” “would,” “will,” “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “continue,” “target,” “project,” “potential,” or similar expressions, or by discussions of strategy, plans or intentions. Forward-looking statements in this press release include, without limitation, statements regarding: the proposed sale of substantially all of the operating assets of Altruis Benefit Consulting; the negotiation and execution of definitive agreements; the anticipated purchase price and its relationship to the Company’s market capitalization; the expected net cash proceeds and the aggregate incremental cash expected to be generated by the proposed transaction; escrow arrangements, post-closing adjustments and timing of any closing; the Company’s intended use of proceeds, including the repayment of its outstanding term debt and the anticipated release of restricted cash; the anticipated effects of the proposed transaction on the Company’s cash position, interest expense, capital structure and financial flexibility; the Company’s strategy of monetizing mature insurance distribution assets and redeploying capital; and the continued development, deployment and potential commercialization of the Company’s proprietary artificial intelligence platform and its RELI Exchange InsurTech platform.
These statements are based on management’s current expectations and assumptions and are subject to risks, uncertainties and other factors, many of which are beyond the Company’s control. Should one or more of these risks or uncertainties materialize, or should any underlying assumptions prove incorrect, actual results may differ materially from those expressed or implied by these forward-looking statements.
Such risks and uncertainties include, without limitation: that the LOI is non-binding as to the proposed transaction terms and either party may discontinue negotiations at any time for any reason or no reason; the risk that definitive agreements are not negotiated or executed; the risk that the buyer’s due diligence is not completed to its satisfaction; the risk that the buyer is unable to obtain financing for the transaction on acceptable terms or at all; the risk that required carrier appointments are not continued or transferred; the risk that existing liens are not released or that required lender, landlord, regulatory or other third-party consents and releases, or board or other required approvals, are not obtained; the risk that closing conditions are not satisfied or waived, or that the transaction is delayed beyond the targeted closing date or terminated; the risk that the final purchase price, escrow amounts or working capital adjustments differ from those described herein; the risk that net proceeds and cash available to the Company are less than anticipated after transaction expenses, income taxes (including any limitation on the Company’s ability to utilize net operating loss carryforwards), escrows and debt repayment; the risk that the lender does not release restricted cash or collateral on the terms or timing anticipated; the fact that the Company’s market capitalization and cash balance fluctuate and comparisons thereto are as of the dates indicated; the loss of the revenue and operating cash flow historically contributed by Altruis and the resulting impact on the Company’s consolidated results of operations; the Company’s ability to maintain compliance with the continued listing standards of The Nasdaq Capital Market; the Company’s ability to access additional capital on acceptable terms, or at all; the development, deployment, market acceptance and potential commercialization of the Company’s proprietary artificial intelligence technologies; competition, regulatory developments and other risks affecting the insurance brokerage and InsurTech industries; and general business, economic, market and geopolitical conditions. Additional information regarding these and other factors that may cause actual results to differ materially is included under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, as amended, and in the Company’s subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission, copies of which are available free of charge at www.sec.gov.
Readers are cautioned not to place undue reliance on forward-looking statements. The forward-looking statements in this press release speak only as of the date of this press release. Except as required by applicable law, the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Investor Relations Contact:
Crescendo Communications, LLC
Tel: +1 (212) 671-1020
Email: EZRA@crescendo-ir.com
Media Contact:
Michael Goldberg
michael@mmstratcomms.com
###